NasdaqCM - Nasdaq Real Time Price USD
NeuroBo Pharmaceuticals, Inc. (NRBO)
As of 11:22 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,900.0000
-10,799.0000
-11,712.0000
-15,134.0000
-10,764.0000
Investing Cash Flow
-54.0000
-50.0000
8.0000
-586.0000
69.0000
Financing Cash Flow
19,200.0000
-80.0000
28,681.0000
22,026.0000
6,858.0000
End Cash Position
27,934.0000
22,435.0000
33,364.0000
16,387.0000
10,089.0000
Capital Expenditure
-54.0000
-50.0000
--
-3.0000
-4.0000
Issuance of Capital Stock
19,998.0000
--
32,250.0000
24,000.0000
7,500.0000
Free Cash Flow
-19,954.0000
-10,849.0000
-11,712.0000
-15,137.0000
-10,768.0000
12/31/2020 - 8/5/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PALI Palisade Bio, Inc.
2.5300
-0.39%
KPRX Kiora Pharmaceuticals, Inc.
3.5350
-0.42%
QNRX Quoin Pharmaceuticals, Ltd.
0.6660
-3.75%
LIXT Lixte Biotechnology Holdings, Inc.
1.6800
+5.00%
PSTV Plus Therapeutics, Inc.
1.2925
-4.96%
PXMD PaxMedica, Inc.
0.0951
0.00%
DRMA Dermata Therapeutics, Inc.
1.3421
+0.16%
ATXI Avenue Therapeutics, Inc.
2.2051
-3.71%
PHIO Phio Pharmaceuticals Corp.
3.1100
-4.89%
COEP Coeptis Therapeutics Holdings, Inc.
0.1999
-3.50%